Patient Guide: Safety of the BRD9 heterobifunctional degrader CFT8634 in synovial sarcoma and _SMARCB1_ -null tumors: an open-label, dose-escalation, phase 1 clinical trial

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 12 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05355753
Status: STOPPED
Condition: synovial sarcoma, SMARCB1-null tumors
Phase: Phase I

Find a Study Location Near You

This study is available at 12 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • St. Louis, MO
  • New York, NY
  • Duarte, CA
  • • And 9 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily